[HTML][HTML] Reinfection with SARS-CoV-2 and Failure of Humoral Immunity: a case report.
…, WR Berrington, GP Pappas, ST Nyatsatsang… - MedRxiv, 2020 - ncbi.nlm.nih.gov
Recovery from COVID-19 is associated with production of anti-SARS-CoV-2 antibodies, but
it is uncertain whether these confer immunity. We describe viral RNA shedding duration in …
it is uncertain whether these confer immunity. We describe viral RNA shedding duration in …
[HTML][HTML] Reinfection with SARS-CoV-2 and waning humoral immunity: a case report
…, WR Berrington, GP Pappas, ST Nyatsatsang… - Vaccines, 2022 - mdpi.com
Recovery from COVID-19 is associated with production of anti-SARS-CoV-2 antibodies, but
it is uncertain whether these confer immunity. We describe viral RNA shedding duration in …
it is uncertain whether these confer immunity. We describe viral RNA shedding duration in …
Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replication (preprint)
…, NW Bartlett, F Mercuri, MW Carroll, ST Nyatsatsang… - 2020 - pesquisa.bvsalud.org
Identifying drugs that regulate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection and its symptoms has been a pressing area of investigation during the …
infection and its symptoms has been a pressing area of investigation during the …
Sequence Analysis for SNP Detection and Phylogenetic Reconstruction of SARS-CoV-2 Isolated from Nigerian COVID-19 Cases (preprint)
…, WR Berrington, GP Pappas, ST Nyatsatsang… - 2020 - pesquisa.bvsalud.org
Background: Coronaviruses are a group of viruses that belong to the Family Coronaviridae,
Genus Betacoronavirus. In December 2019, a new coronavirus disease (COVID-19) …
Genus Betacoronavirus. In December 2019, a new coronavirus disease (COVID-19) …
[HTML][HTML] Use of the IL‐6R antagonist tocilizumab in hospitalized COVID‐19 patients
…, A Islam, C Maree, S Nyatsatsang… - Journal of internal …, 2021 - ncbi.nlm.nih.gov
Methods This retrospective cohort study included 42 adults (≥ 18 years old) hospitalized for
COVID‐19 and treated with tocilizumab at Swedish Medical Center (Seattle, USA) between …
COVID‐19 and treated with tocilizumab at Swedish Medical Center (Seattle, USA) between …
[HTML][HTML] Ceftobiprole for Staphylococcus aureus Bacteremia. Reply
HM Biggs, EAF Simões, IA Khader… - N Engl J …, 2023 - hyc.globalhealth.duke.edu
Citation: Smith, CM and M. Vendrame, Perspective: A resident’s role in promoting safe
machine-learning tools in sleep medicine. J Clin Sleep Med, 2023. 19 (11): p. 1985-1987. …
machine-learning tools in sleep medicine. J Clin Sleep Med, 2023. 19 (11): p. 1985-1987. …
Cryptic transmission of SARS-CoV-2 in Washington state
After its emergence in Wuhan, China, in late November or early December 2019, the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus rapidly spread globally. …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus rapidly spread globally. …
Multiomic immunophenotyping of COVID-19 patients reveals early infection trajectories
Host immune responses play central roles in controlling SARS-CoV2 infection, yet remain
incompletely characterized and understood. Here, we present a comprehensive immune …
incompletely characterized and understood. Here, we present a comprehensive immune …
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a …
…, E Dishner, A Vekstein, ER Ko, T Der… - The Lancet Infectious …, 2022 - thelancet.com
Background We aimed to assess the efficacy and safety of two neutralising monoclonal
antibody therapies (sotrovimab [Vir Biotechnology and GlaxoSmithKline] and BRII-196 plus BRII-…
antibody therapies (sotrovimab [Vir Biotechnology and GlaxoSmithKline] and BRII-196 plus BRII-…
[CITATION][C] Evaluation of Myobacterium Tuberculosis Specific Antigen Interferon Gamma Release Assays in HIV Infected Subjects
ST Nyatsatsang - 2007 - Boston University